Elinzanetant reduces the severity and frequency of hot flushes and night sweats among women with breast cancer regardless of ...

Incidence and diagnosis of neuroendocrine tumors (NETs) have risen significantly over the last several decades. According to research published in JAMA Network Open in 2025, the incidence of NETs ...

Menopause drug Elinzanetant cuts hot flush frequency and severity in breast cancer patients on any hormone therapy, providing a safer, non-hormonal relief.

Radiologic surveillance of nonfunctional pituitary adenomas provided only minimal benefits for patients with multiple ...

The condition is best understood as a symptom-based disorder of altered pain processing with partial overlap with post-viral ...

When people think about breast cancer treatment, they usually picture chemotherapy, radiation, and surgery. But for many of ...

Peer-reviewed research from the Clayman Thyroid Center at the Hospital for Endocrine Surgery highlights a major gap in ...

Results from the OASIS 4 clinical trial show that a new drug, elinzanetant, relieved hot flashes and night sweats that can ...

Understand the signs of premature ovarian failure and POI. Learn how to manage symptoms and protect your long-term health.

Results from the OASIS 4 clinical trial last year showed that a new drug, elinzanetant, relieved hot flushes and night sweats that can occur because of the menopause or because of hormone treatment ...

Results from the OASIS 4 clinical trial last year showed that a new drug, elinzanetant, relieved hot flushes and night sweats that ...

A study reveals 26% of Type-2 diabetics have hidden liver fibrosis, urging early detection to prevent severe complications.